Dermatology
Feature
Dermatologists take to TikTok to share their own ‘hacks’
Laypeople are still the dominant producers – and have the most views – of dermatology content on TikTok.
Latest News
iPLEDGE rollout described as a failure, chaotic, and a disaster
The switch to a new platform was met with frustration from physicians, pharmacists, and patients alike.
Conference Coverage
How does atopic dermatitis present in skin of color?
Morphological variants common in skin of color include the follicular variant or micropapular variant of AD.
Conference Coverage
Abrocitinib efficacy dose-dependent, similar across AD age groups
“We know that responses to, and adverse events associated with, systemic therapies may vary among patients of different ages.”
Conference Coverage
CRP elevated in adults with AD and sleep disturbance
“There is a consequence of not treating patients with atopic dermatitis, especially those patients with sleep disturbance.”
Opinion
A 22-year-old presented with erythematous papules on her fingers and toes
A 22-year-old with a history of ITP presented with 2 months of asymptomatic erythematous papules on her fingers and toes.
Latest News
Abrocitinib approved for atopic dermatitis in Europe
Approval was based on the results of studies that include four phase 3 clinical trials and an ongoing open-label extension study.
Latest News
FDA expands pembrolizumab approval for advanced melanoma
Approval was based on first interim findings from the randomized, placebo-controlled KEYNOTE-716 trial, which evaluated patients with stage IIB...
From the Journals
Pink or red actinic keratoses signal more inflammation
Retrospective study supports novel use of color to triage AKs and reduce need for biopsy.
From the Journals
‘Highest survival’ with combo immunotherapy in advanced melanoma
The results represent the longest median overall survival seen in a phase 3 trial of advanced melanoma.
From the Journals
Differences in response to immunotherapy in men versus women
It remains unclear whether the increased risk for death in women is a result of treatment side effects or lack of efficacy.